SBC Medical Group Holdings (SBC) closed at $5.28 on October 23, 2026, down 7.2% from the previous close, on volume of 289,592 shares (30-day average 206,811).
Data as of October 23, 2026.
23-Oct-2026
SBC Medical Initiates Development of a DNA Methylation Test to Estimate Biological Age
Business Wire (Thu, 22-Oct 9:00 AM ET)
SBC Medical to Present at Cantor Fitzgerald Hong Kong's Inaugural Asia Longevity Forum
Globe Newswire (Mon, 12-Oct 9:00 AM ET)
SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026
Globe Newswire (Fri, 25-Sep 9:00 AM ET)
SBC Set to Present at Sidoti’s September Small-Cap Virtual Conference on September 24
Market Chameleon (Tue, 22-Sep 7:59 AM ET)
Sidoti Events, LLC's September Small-Cap Virtual Conference
ACCESS Newswire (Tue, 22-Sep 9:46 AM ET)
SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026
Business Wire (Tue, 1-Sep 1:35 PM ET)
ACCESS Newswire (Thu, 27-Aug 5:30 PM ET)
ACCESS Newswire (Mon, 24-Aug 3:45 PM ET)
Presenting on Emerging Growth Conference 95 Day 2 on August 20; Register to live stream
Globe Newswire (Wed, 19-Aug 7:00 AM ET)
Presenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live stream
Globe Newswire (Tue, 18-Aug 7:00 AM ET)
SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). The firm generates revenue mostly from these management services.
SBC Medical Group Holdings trades on the NASDAQ stock market under the symbol SBC.
As of October 23, 2026, SBC stock price declined to $5.28 with 289,592 million shares trading.
SBC has a beta of -0.16, meaning it tends to be less sensitive to market movements. SBC has a correlation of 0.00 to the broad based SPY ETF.
SBC has a market cap of $543.03 million. This is considered a Small Cap stock.
Last quarter SBC Medical Group Holdings reported $49 million in Revenue and $.10 earnings per share. This beat revenue expectation by $4 million and missed earnings estimates by -$.02.
The top ETF exchange traded funds that SBC belongs to (by Net Assets): IWM, VXF, IWN, AVUV, VTWO.
SBC has outperformed the market in the last year with a return of +35.0%, while the SPY ETF gained +14.3%. In the last 3 month period, SBC beat the market returning +80.2%, while SPY returned +3.2%. However, in the most recent 2 weeks SBC has underperformed the stock market by returning -2.6%, while SPY returned -2.4%.
SBC support price is $5.51 and resistance is $5.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SBC shares will trade within this expected range on the day.
